Organigram Global (OGI) Non-cash Items (2019 - 2026)
Organigram Global (OGI) posted quarterly Non-cash Items of -$21.5 billion for Q1 2026, down 323.52% year-over-year from $9.6 billion in Q1 2025, and down 143828307.77% quarter-over-quarter from -$14920.4 in Q4 2025.
Organigram Global (OGI) Non-cash Items (2019 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Non-cash Items for 4 consecutive years, with -$21.5 billion the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Organigram Global | 152.06 Mn | 151.94 Mn | 28.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.46 Bn |
| Mar 31, 2026 | -21.46 Bn |
| Dec 31, 2025 | -14,920.41 |
| Dec 31, 2025 | -14,920.41 |
| Mar 31, 2025 | 9.60 Bn |
| Mar 31, 2025 | 9.60 Bn |
| Dec 31, 2024 | -47,199.51 |
| Dec 31, 2024 | -47,199.51 |
| Nov 25, 2019 | 19.90 Mn |
| Nov 25, 2019 | 19.90 Mn |